SCHEMBL9942192

SCHEMBL9942192

CC(C)CNc1nc(-c2ccc3ccccc3c2)cn2c(-c3ccc(C(N)=O)c(C4CC4)c3)cnc12

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TTK P33981 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9940431 0.91 TTK (0.55) TTK
SCHEMBL9942210 0.90 TTK (0.57) TTK
SCHEMBL9942749 0.90 TTK (0.55) TTK
SCHEMBL9942244 0.90 TTK (0.56) TTK
SCHEMBL9942235 0.90 TTK (0.56) TTK
SCHEMBL9942731 0.90 TTK (0.56) TTK
SCHEMBL9942245 0.90 TTK (0.56) TTK
SCHEMBL9942250 0.90 TTK (0.54) TTK
SCHEMBL9942175 0.90 TTK (0.56) TTK
SCHEMBL9942735 0.89 TTK (0.54) TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651950-A1 6 SUBSTITUTED IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS Bayer Intellectual Property GmbH (DE) 2013-10-23 EP claimed
WO-2012080230-A1 6 SUBSTITUTED IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-06-21 WO claimed